[1] | Neil SJ (2013) The antiviral activities of tetherin. Curr Top Microbiol Immunol 371: 67–104. doi: 10.1007/978-3-642-37765-5_3. pmid:23686232
|
[2] | Jia B, Serra-Moreno R, Neidermyer W, Rahmberg A, Mackey J, et al. (2009) Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2. PLoS Pathog 5: e1000429. doi: 10.1371/journal.ppat.1000429. pmid:19436700
|
[3] | Le Tortorec A, Neil SJ (2009) Antagonism to and intracellular sequestration of human tetherin by the human immunodeficiency virus type 2 envelope glycoprotein. J Virol 83: 11966–11978. doi: 10.1128/JVI.01515-09. pmid:19740980
|
[4] | Neil SJ, Zang T, Bieniasz PD (2008) Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451: 425–430. doi: 10.1038/nature06553. pmid:18200009
|
[5] | Van Damme N, Goff D, Katsura C, Jorgenson RL, Mitchell R, et al. (2008) The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe 3: 245–252. doi: 10.1016/j.chom.2008.03.001. pmid:18342597
|
[6] | Zhang F, Landford WN, Ng M, McNatt MW, Bieniasz PD, et al. (2011) SIV Nef proteins recruit the AP-2 complex to antagonize Tetherin and facilitate virion release. PLoS Pathog 7: e1002039. doi: 10.1371/journal.ppat.1002039. pmid:21625568
|
[7] | Perez-Caballero D, Zang T, Ebrahimi A, McNatt MW, Gregory DA, et al. (2009) Tetherin inhibits HIV-1 release by directly tethering virions to cells. Cell 139: 499–511. doi: 10.1016/j.cell.2009.08.039. pmid:19879838
|
[8] | Venkatesh S, Bieniasz PD (2013) Mechanism of HIV-1 virion entrapment by tetherin. PLoS Pathog 9: e1003483. doi: 10.1371/journal.ppat.1003483. pmid:23874200
|
[9] | Alvarez RA, Hamlin RE, Monroe A, Moldt B, Hotta MT, et al. (2014) HIV-1 Vpu antagonism of tetherin inhibits antibody-dependent cellular cytotoxic responses by natural killer cells. J Virol 88: 6031–6046. doi: 10.1128/JVI.00449-14. pmid:24623433
|
[10] | Arias JF, Heyer LN, von Bredow B, Weisgrau KL, Moldt B, et al. (2014) Tetherin antagonism by Vpu protects HIV-infected cells from antibody-dependent cell-mediated cytotoxicity. Proc Natl Acad Sci U S A 111: 6425–6430. doi: 10.1073/pnas.1321507111. pmid:24733916
|
[11] | Pham TN, Lukhele S, Hajjar F, Routy JP, Cohen EA (2014) HIV Nef and Vpu protect HIV-infected CD4+ T cells from antibody-mediated cell lysis through down-modulation of CD4 and BST2. Retrovirology 11: 15. doi: 10.1186/1742-4690-11-15. pmid:24498878
|
[12] | Veillette M, Desormeaux A, Medjahed H, Gharsallah NE, Coutu M, et al. (2014) Interaction with cellular CD4 exposes HIV-1 envelope epitopes targeted by antibody-dependent cell-mediated cytotoxicity. J Virol 88: 2633–2644. doi: 10.1128/JVI.03230-13. pmid:24352444
|
[13] | Cocka LJ, Bates P (2012) Identification of alternatively translated Tetherin isoforms with differing antiviral and signaling activities. PLoS Pathog 8: e1002931. doi: 10.1371/journal.ppat.1002931. pmid:23028328
|
[14] | Galao RP, Le Tortorec A, Pickering S, Kueck T, Neil SJ (2012) Innate sensing of HIV-1 assembly by Tetherin induces NFkappaB-dependent proinflammatory responses. Cell Host Microbe 12: 633–644. doi: 10.1016/j.chom.2012.10.007. pmid:23159053
|
[15] | Galao RP, Pickering S, Curnock R, Neil SJ (2014) Retroviral Retention Activates a Syk-Dependent HemITAM in Human Tetherin. Cell Host Microbe 16: 291–303. doi: 10.1016/j.chom.2014.08.005. pmid:25211072
|
[16] | Tokarev A, Suarez M, Kwan W, Fitzpatrick K, Singh R, et al. (2013) Stimulation of NF-kappaB Activity by the HIV Restriction Factor BST2. J Virol 87: 2046–2057. doi: 10.1128/JVI.02272-12. pmid:23221546
|
[17] | Rollason R, Korolchuk V, Hamilton C, Schu P, Banting G (2007) Clathrin-mediated endocytosis of a lipid-raft-associated protein is mediated through a dual tyrosine motif. J Cell Sci 120: 3850–3858. pmid:17940069 doi: 10.1242/jcs.003343
|
[18] | McNatt MW, Zang T, Bieniasz PD (2013) Vpu binds directly to tetherin and displaces it from nascent virions. PLoS Pathog 9: e1003299. doi: 10.1371/journal.ppat.1003299. pmid:23633949
|
[19] | Skasko M, Wang Y, Tian Y, Tokarev A, Munguia J, et al. (2012) HIV-1 Vpu protein antagonizes innate restriction factor BST-2 via lipid-embedded helix-helix interactions. J Biol Chem 287: 58–67. doi: 10.1074/jbc.M111.296772. pmid:22072710
|
[20] | Vigan R, Neil SJ (2010) Determinants of tetherin antagonism in the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein. J Virol 84: 12958–12970. doi: 10.1128/JVI.01699-10. pmid:20926557
|
[21] | Agromayor M, Soler N, Caballe A, Kueck T, Freund SM, et al. (2012) The UBAP1 subunit of ESCRT-I interacts with ubiquitin via a SOUBA domain. Structure 20: 414–428. doi: 10.1016/j.str.2011.12.013. pmid:22405001
|
[22] | Janvier K, Pelchen-Matthews A, Renaud JB, Caillet M, Marsh M, et al. (2011) The ESCRT-0 component HRS is required for HIV-1 Vpu-mediated BST-2/tetherin down-regulation. PLoS Pathog 7: e1001265. doi: 10.1371/journal.ppat.1001265. pmid:21304933
|
[23] | Douglas JL, Viswanathan K, McCarroll MN, Gustin JK, Fruh K, et al. (2009) Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a {beta}TrCP-dependent mechanism. J Virol 83: 7931–7947. doi: 10.1128/JVI.00242-09. pmid:19515779
|
[24] | Mangeat B, Gers-Huber G, Lehmann M, Zufferey M, Luban J, et al. (2009) HIV-1 Vpu neutralizes the antiviral factor Tetherin/BST-2 by binding it and directing its beta-TrCP2-dependent degradation. PLoS Pathog 5: e1000574. doi: 10.1371/journal.ppat.1000574. pmid:19730691
|
[25] | Mitchell RS, Katsura C, Skasko MA, Fitzpatrick K, Lau D, et al. (2009) Vpu antagonizes BST-2-mediated restriction of HIV-1 release via beta-TrCP and endo-lysosomal trafficking. PLoS Pathog 5: e1000450. doi: 10.1371/journal.ppat.1000450. pmid:19478868
|
[26] | Schubert U, Schneider T, Henklein P, Hoffmann K, Berthold E, et al. (1992) Human-immunodeficiency-virus-type-1-enco?dedVpu protein is phosphorylated by casein kinase II. Eur J Biochem 204: 875–883. pmid:1541298 doi: 10.1111/j.1432-1033.1992.tb16707.x
|
[27] | Schubert U, Henklein P, Boldyreff B, Wingender E, Strebel K, et al. (1994) The human immunodeficiency virus type 1 encoded Vpu protein is phosphorylated by casein kinase-2 (CK-2) at positions Ser52 and Ser56 within a predicted alpha-helix-turn-alpha-helix-motif. J Mol Biol 236: 16–25. pmid:8107101 doi: 10.1006/jmbi.1994.1114
|
[28] | Margottin F, Bour SP, Durand H, Selig L, Benichou S, et al. (1998) A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. Mol Cell 1: 565–574. pmid:9660940 doi: 10.1016/s1097-2765(00)80056-8
|
[29] | Tokarev AA, Munguia J, Guatelli JC (2011) Serine-threonine ubiquitination mediates downregulation of BST-2/tetherin and relief of restricted virion release by HIV-1 Vpu. J Virol 85: 51–63. doi: 10.1128/JVI.01795-10. pmid:20980512
|
[30] | Andrew AJ, Miyagi E, Strebel K (2011) Differential effects of human immunodeficiency virus type 1 Vpu on the stability of BST-2/tetherin. J Virol 85: 2611–2619. doi: 10.1128/JVI.02080-10. pmid:21191020
|
[31] | Schubert U, Strebel K (1994) Differential activities of the human immunodeficiency virus type 1-encoded Vpu protein are regulated by phosphorylation and occur in different cellular compartments. J Virol 68: 2260–2271. pmid:8139011
|
[32] | Tervo HM, Homann S, Ambiel I, Fritz JV, Fackler OT, et al. (2011) beta-TrCP is dispensable for Vpu's ability to overcome the CD317/Tetherin-imposed restriction to HIV-1 release. Retrovirology 8: 9. doi: 10.1186/1742-4690-8-9. pmid:21310048
|
[33] | Schmidt S, Fritz JV, Bitzegeio J, Fackler OT, Keppler OT (2011) HIV-1 Vpu blocks recycling and biosynthetic transport of the intrinsic immunity factor CD317/tetherin to overcome the virion release restriction. MBio 2: e00036–00011. doi: 10.1128/mBio.00036-11. pmid:21610122
|
[34] | Pickering S, Hue S, Kim EY, Reddy S, Wolinsky SM, et al. (2014) Preservation of tetherin and CD4 counter-activities in circulating Vpu alleles despite extensive sequence variation within HIV-1 infected individuals. PLoS Pathog 10: e1003895. doi: 10.1371/journal.ppat.1003895. pmid:24465210
|
[35] | Dube M, Paquay C, Roy BB, Bego MG, Mercier J, et al. (2011) HIV-1 Vpu antagonizes BST-2 by interfering mainly with the trafficking of newly synthesized BST-2 to the cell surface. Traffic 12: 1714–1729. doi: 10.1111/j.1600-0854.2011.01277.x. pmid:21902775
|
[36] | Kueck T, Neil SJ (2012) A cytoplasmic tail determinant in HIV-1 Vpu mediates targeting of tetherin for endosomal degradation and counteracts interferon-induced restriction. PLoS Pathog 8: e1002609. doi: 10.1371/journal.ppat.1002609. pmid:22479182
|
[37] | Bonifacino JS, Traub LM (2003) Signals for sorting of transmembrane proteins to endosomes and lysosomes. Annu Rev Biochem 72: 395–447. pmid:12651740
|
[38] | Lau D, Kwan W, Guatelli J (2011) Role of the endocytic pathway in the counteraction of BST-2 by human lentiviral pathogens. J Virol 85: 9834–9846. doi: 10.1128/JVI.02633-10. pmid:21813615
|
[39] | Jia X, Weber E, Tokarev A, Lewinski M, Rizk M, et al. (2014) Structural basis of HIV-1 Vpu-mediated BST2 antagonism via hijacking of the clathrin adaptor protein complex 1. Elife 3: e02362. doi: 10.7554/eLife.02362. pmid:24843023
|
[40] | Weinelt J, Neil SJ (2014) Differential sensitivities of tetherin isoforms to counteraction by primate lentiviruses. J Virol 88: 5845–5858. doi: 10.1128/JVI.03818-13. pmid:24623426
|
[41] | Serra-Moreno R, Jia B, Breed M, Alvarez X, Evans DT (2011) Compensatory changes in the cytoplasmic tail of gp41 confer resistance to tetherin/BST-2 in a pathogenic nef-deleted SIV. Cell Host Microbe 9: 46–57. doi: 10.1016/j.chom.2010.12.005. pmid:21238946
|
[42] | Zhang F, Wilson SJ, Landford WC, Virgen B, Gregory D, et al. (2009) Nef proteins from simian immunodeficiency viruses are tetherin antagonists. Cell Host Microbe 6: 54–67. doi: 10.1016/j.chom.2009.05.008. pmid:19501037
|
[43] | Mauxion F, Le Borgne R, Munier-Lehmann H, Hoflack B (1996) A casein kinase II phosphorylation site in the cytoplasmic domain of the cation-dependent mannose 6-phosphate receptor determines the high affinity interaction of the AP-1 Golgi assembly proteins with membranes. J Biol Chem 271: 2171–2178. pmid:8567675 doi: 10.1074/jbc.271.4.2171
|
[44] | McDonald B, Martin-Serrano J (2008) Regulation of Tsg101 expression by the steadiness box: a role of Tsg101-associated ligase. Mol Biol Cell 19: 754–763. pmid:18077552 doi: 10.1091/mbc.e07-09-0957
|
[45] | Martin-Serrano J, Neil SJ (2011) Host factors involved in retroviral budding and release. Nat Rev Microbiol 9: 519–531. doi: 10.1038/nrmicro2596. pmid:21677686
|
[46] | Hirano S, Kawasaki M, Ura H, Kato R, Raiborg C, et al. (2006) Double-sided ubiquitin binding of Hrs-UIM in endosomal protein sorting. Nat Struct Mol Biol 13: 272–277. pmid:16462748 doi: 10.1038/nsmb1051
|
[47] | Tokarev A, Guatelli J (2011) Misdirection of membrane trafficking by HIV-1 Vpu and Nef: Keys to viral virulence and persistence. Cell Logist 1: 90–102. pmid:21922073 doi: 10.4161/cl.1.3.16708
|
[48] | Miyagi E, Andrew AJ, Kao S, Strebel K (2009) Vpu enhances HIV-1 virus release in the absence of Bst-2 cell surface down-modulation and intracellular depletion. Proc Natl Acad Sci U S A 106: 2868–2873. doi: 10.1073/pnas.0813223106. pmid:19196977
|
[49] | Coadou G, Evrard-Todeschi N, Gharbi-Benarous J, Benarous R, Girault JP (2002) HIV-1 encoded virus protein U (Vpu) solution structure of the 41–62 hydrophilic region containing the phosphorylated sites Ser52 and Ser56. Int J Biol Macromol 30: 23–40. pmid:11893391 doi: 10.1016/s0141-8130(01)00184-2
|
[50] | Coadou G, Gharbi-Benarous J, Megy S, Bertho G, Evrard-Todeschi N, et al. (2003) NMR studies of the phosphorylation motif of the HIV-1 protein Vpu bound to the F-box protein beta-TrCP. Biochemistry 42: 14741–14751. pmid:14674748 doi: 10.1021/bi035207u
|
[51] | Willbold D, Hoffmann S, Rosch P (1997) Secondary structure and tertiary fold of the human immunodeficiency virus protein U (Vpu) cytoplasmic domain in solution. Eur J Biochem 245: 581–588. pmid:9182993 doi: 10.1111/j.1432-1033.1997.t01-1-00581.x
|
[52] | Wittlich M, Koenig BW, Stoldt M, Schmidt H, Willbold D (2009) NMR structural characterization of HIV-1 virus protein U cytoplasmic domain in the presence of dodecylphosphatidylcholine micelles. FEBS J 276: 6560–6575. doi: 10.1111/j.1742-4658.2009.07363.x. pmid:19804408
|
[53] | Jafari M, Guatelli J, Lewinski MK (2014) Activities of transmitted/founder and chronic clade B HIV-1 Vpu and a C-terminal polymorphism specifically affecting virion release. J Virol 88: 5062–5078. doi: 10.1128/JVI.03472-13. pmid:24574397
|
[54] | Wittlich M, Koenig BW, Willbold D (2008) Structural consequences of phosphorylation of two serine residues in the cytoplasmic domain of HIV-1 VpU. J Pept Sci 14: 804–810. doi: 10.1002/psc.1004. pmid:18186541
|
[55] | Miyakawa K, Sawasaki T, Matsunaga S, Tokarev A, Quinn G, et al. (2012) Interferon-induced SCYL2 limits release of HIV-1 by triggering PP2A-mediated dephosphorylation of the viral protein Vpu. Sci Signal 5: ra73. doi: 10.1126/scisignal.2003212. pmid:23047923
|
[56] | Serra-Moreno R, Zimmermann K, Stern LJ, Evans DT (2013) Tetherin/BST-2 antagonism by Nef depends on a direct physical interaction between Nef and tetherin, and on clathrin-mediated endocytosis. PLoS Pathog 9: e1003487. doi: 10.1371/journal.ppat.1003487. pmid:23853598
|
[57] | Pardieu C, Vigan R, Wilson SJ, Calvi A, Zang T, et al. (2010) The RING-CH ligase K5 antagonizes restriction of KSHV and HIV-1 particle release by mediating ubiquitin-dependent endosomal degradation of tetherin. PLoS Pathog 6: e1000843. doi: 10.1371/journal.ppat.1000843. pmid:20419159
|
[58] | Neil SJ, Eastman SW, Jouvenet N, Bieniasz PD (2006) HIV-1 Vpu promotes release and prevents endocytosis of nascent retrovirus particles from the plasma membrane. PLoS Pathog 2: e39. pmid:16699598 doi: 10.1371/journal.ppat.0020039
|
[59] | Martin-Serrano J, Yarovoy A, Perez-Caballero D, Bieniasz PD (2003) Divergent retroviral late-budding domains recruit vacuolar protein sorting factors by using alternative adaptor proteins. Proc Natl Acad Sci U S A 100: 12414–12419. pmid:14519844 doi: 10.1073/pnas.2133846100
|
[60] | Maldarelli F, Chen MY, Willey RL, Strebel K (1993) Human immunodeficiency virus type 1 Vpu protein is an oligomeric type I integral membrane protein. J Virol 67: 5056–5061. pmid:8331740
|
[61] | Roux KJ, Kim DI, Raida M, Burke B (2012) A promiscuous biotin ligase fusion protein identifies proximal and interacting proteins in mammalian cells. J Cell Biol 196: 801–810. doi: 10.1083/jcb.201112098. pmid:22412018
|